SCHEMBL25880383

SCHEMBL25880383

c1ccc(-c2cccc(-c3ccc4c5c3c3ccccc3n5c3ccc(-c5ccccc5-c5ccccc5)c5c6ccccc6n4c53)c2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.33
MEN1 O00255 2/20 0.33
MAPT P10636 2/20 0.33
KMT2A Q03164 2/20 0.33
APAF1 O14727 1/20 0.33
NPC1 O15118 1/20 0.33
LMNA P02545 1/20 0.33
THRB P10828 1/20 0.33
XBP1 P17861 1/20 0.33
PTBP1 P26599 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33
GALK1 P51570 1/20 0.33
BLM P54132 1/20 0.33
SMAD3 P84022 1/20 0.33
ATM Q13315 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
PRKDC P78527 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25880382 0.93 HSD17B10 (0.36) HSD17B10L3MBTL1MEN1MAPTKMT2A
SCHEMBL25880375 0.90 HSD17B10 (0.38) HSD17B10MAPTNPC1RAB9ACRHBP
SCHEMBL25880402 0.86 HSD17B10 (0.37) HSD17B10L3MBTL1MAPTALDH1A1HPGD
SCHEMBL25880354 0.85 HSD17B10 (0.41) HSD17B10L3MBTL1MEN1MAPTKMT2A
SCHEMBL25880419 0.84 MEN1 (0.34) HSD17B10L3MBTL1MEN1MAPTKMT2A
SCHEMBL25880422 0.84 ALK (0.35) L3MBTL1MEN1MAPTKMT2AAPAF1
SCHEMBL21262984 0.82 HSD17B10 (0.35) HSD17B10L3MBTL1MEN1MAPTKMT2A
SCHEMBL21126985 0.82 HSD17B10 (0.31) HSD17B10PRKDCMAPK14PTGER1PTGER4
SCHEMBL26026961 0.81 MEN1 (0.33) HSD17B10L3MBTL1MEN1MAPTKMT2A
SCHEMBL20857879 0.81 HSD17B10 (0.34) HSD17B10MEN1MAPTKMT2APRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230240135-A1 HETEROCYLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-07-27 US disclosed
US-20230240135-A1 HETEROCYLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230240135-A1 HETEROCYLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE CRY1, LAGE3, NQO1 HSD17B10 1229/4885L3MBTL1 1282/4885MEN1 249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.